Mark J. Axelrod

546 total citations
15 papers, 387 citations indexed

About

Mark J. Axelrod is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Mark J. Axelrod has authored 15 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Hematology. Recurrent topics in Mark J. Axelrod's work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Melanoma and MAPK Pathways (3 papers). Mark J. Axelrod is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Melanoma and MAPK Pathways (3 papers). Mark J. Axelrod collaborates with scholars based in United States and Egypt. Mark J. Axelrod's co-authors include Michael J. Weber, Vicki L. Gordon, T. McMahon, Thomas S. Maxey, Brian J. Capaldo, Anne C. Eischeid, Jaclyn Kline, Andrew J. Gow, Matthew J. Gurka and Allan Doctor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Mark J. Axelrod

15 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Axelrod United States 8 127 117 116 80 73 15 387
Benjamin Y. Owusu United States 12 145 1.1× 72 0.6× 30 0.3× 33 0.4× 87 1.2× 16 388
Lee C. Preusser United States 8 290 2.3× 81 0.7× 60 0.5× 32 0.4× 84 1.2× 11 544
Thomas Biel United States 10 214 1.7× 60 0.5× 96 0.8× 23 0.3× 34 0.5× 22 562
Azadali Moorji Saudi Arabia 10 258 2.0× 35 0.3× 67 0.6× 120 1.5× 84 1.2× 17 406
Katharina von Löhneysen United States 10 215 1.7× 211 1.8× 43 0.4× 14 0.2× 48 0.7× 12 501
Jutta Meyer-Kirchrath Germany 15 211 1.7× 82 0.7× 20 0.2× 33 0.4× 38 0.5× 24 652
Yachao Yao China 10 189 1.5× 41 0.4× 23 0.2× 25 0.3× 31 0.4× 19 364
Manuela Salvucci Ireland 14 213 1.7× 40 0.3× 37 0.3× 32 0.4× 98 1.3× 32 420
Debora Soncini Italy 13 272 2.1× 95 0.8× 12 0.1× 43 0.5× 295 4.0× 24 827
Chandrashekar R. Ambati United States 12 375 3.0× 52 0.4× 18 0.2× 30 0.4× 87 1.2× 14 637

Countries citing papers authored by Mark J. Axelrod

Since Specialization
Citations

This map shows the geographic impact of Mark J. Axelrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Axelrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Axelrod more than expected).

Fields of papers citing papers by Mark J. Axelrod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Axelrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Axelrod. The network helps show where Mark J. Axelrod may publish in the future.

Co-authorship network of co-authors of Mark J. Axelrod

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Axelrod. A scholar is included among the top collaborators of Mark J. Axelrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Axelrod. Mark J. Axelrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Khalil, Ashraf A., Mark J. Axelrod, Abel P. David, et al.. (2019). Antitumor effect of insulin‐like growth factor‐1 receptor inhibition in head and neck squamous cell carcinoma. The Laryngoscope. 130(6). 1470–1478. 5 indexed citations
2.
Jayappa, Kallesh D., Craig A. Portell, Vicki L. Gordon, et al.. (2017). Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Advances. 1(14). 933–946. 81 indexed citations
3.
Jones, Randall M., Mark J. Axelrod, Daniel B. Tumas, Christophe Quéva, & Julie Di Paolo. (2015). Combination Effects of B Cell Receptor Pathway Inhibitors (Entospletinib, ONO/GS-4059, and Idelalisib) and a BCL-2 Inhibitor in Primary CLL Cells. Blood. 126(23). 1749–1749. 11 indexed citations
4.
5.
Capaldo, Brian J., Mark J. Axelrod, Alexander F. Koeppel, et al.. (2015). Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma. PLoS ONE. 10(9). e0138210–e0138210. 6 indexed citations
6.
Portell, Craig A., Mark J. Axelrod, Vicki L. Gordon, et al.. (2015). Abstract B40: Synergistic cytotoxicity of ibrutinib and the BCL2 antagonist ABT-199 in mantle cell lymphoma and chronic lymphocytic leukemia: Molecular analysis reveals mechanisms of target interactions.. Clinical Cancer Research. 21(17_Supplement). B40–B40. 1 indexed citations
7.
Axelrod, Mark J., Vicki L. Gordon, Stephanie Leimgruber, et al.. (2014). p70S6 kinase is a critical node that integrates HER-family and PI3 kinase signaling networks. Cellular Signalling. 26(8). 1627–1635. 7 indexed citations
8.
9.
Axelrod, Mark J., Ashraf A. Khalil, Stephanie Leimgruber, et al.. (2014). Synergistic apoptosis in head and neck squamous cell carcinoma cells by co‐inhibition of insulin‐like growth factor‐1 receptor signaling and compensatory signaling pathways. Head & Neck. 37(12). 1722–1732. 6 indexed citations
10.
11.
Axelrod, Mark J., Vicki L. Gordon, Mark R. Conaway, et al.. (2013). Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms. Oncotarget. 4(4). 622–635. 35 indexed citations
12.
Axelrod, Mark J., Daniel Gioeli, Elizabeth R. Sharlow, et al.. (2013). Abstract 5633: Co-targeting the IGF1R pathway and compensatory signaling enhances cytotoxicity in head and neck cancer.. Cancer Research. 73(8_Supplement). 5633–5633. 5 indexed citations
13.
Axelrod, Mark J., Brian J. Capaldo, Karin Jensen, et al.. (2012). Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma. Molecular Cancer Therapeutics. 11(11). 2505–2515. 29 indexed citations
14.
Axelrod, Mark J., Daniel Gioeli, & Michael J. Weber. (2010). Abstract 1650: Targeting of compensatory signaling pathways identified in a synthetic lethal screen leads to synergistic growth inhibition in bladder cancer cells. Cancer Research. 70(8_Supplement). 1650–1650. 1 indexed citations
15.
Doctor, Allan, Anne C. Eischeid, T. McMahon, et al.. (2005). Hemoglobin conformation couples erythrocyte S -nitrosothiol content to O 2 gradients. Proceedings of the National Academy of Sciences. 102(16). 5709–5714. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Y. Owusu Breakdown of academic impact, for papers by Lee C. Preusser Breakdown of academic impact, for papers by Thomas Biel Breakdown of academic impact, for papers by Azadali Moorji Breakdown of academic impact, for papers by Katharina von Löhneysen Breakdown of academic impact, for papers by Jutta Meyer-Kirchrath Breakdown of academic impact, for papers by Yachao Yao Breakdown of academic impact, for papers by Manuela Salvucci Breakdown of academic impact, for papers by Debora Soncini Breakdown of academic impact, for papers by Chandrashekar R. Ambati
Rankless by CCL
2026